Dynamic and results-driven Senior Pharmaceutical Quality Leader with over 20 years of progressive experience in Quality Control, Quality Assurance, and Corporate Quality functions across leading pharmaceutical organizations. Recognized as a Data Integrity expert and Certified Lead Auditor, with deep expertise in Computerized System Validation (CSV), IT Quality Assurance, and regulatory frameworks including 21 CFR Parts 11 & 211, and EU Annex 11.
Demonstrates a proven track record in regulatory compliance, investigations (OOS, deviations, market complaints, product recalls), and implementation of robust quality systems. Adept at conducting comprehensive audits of external manufacturers, testing laboratories, and CSV service providers, ensuring end-to-end GMP compliance across global supply chains.
A strategic thinker and transformational leader, skilled in leading cross-functional teams through successful regulatory inspections (USFDA, MHRA, EU-GMP, SAPHRA, ANVISA), while driving digital innovation, including automation and AI-based solutions, to enhance operational excellence and data integrity.
Committed to upholding the highest standards of pharmaceutical quality and compliance, while fostering a culture of continuous improvement and proactive risk management.
Data Integrity
undefinedRecipient of the "Artificial Intelligence Pioneer Award" at the Pharma Quality Excellence Awards 2025 by the EBM Group, in recognition of developing the innovative Root Cause Analysis using Artificial Intelligence (RCAI) application. This cutting-edge tool transformed the pharmaceutical investigation process by leveraging AI for root cause identification, hypothesis generation, impact assessment, CAPA recommendation, and automated training content creation, significantly enhancing investigation efficiency, consistency, and regulatory compliance.
Approved Chemist by Department of Foods and Drugs Administration (Goa FDA), Government of Goa, India, as an Expert in Chemical and Instrumentation, vide certificate No. 66(2637)/MFG/APP/DFDA/06/11227
Invention of Bi-layer tablet formulations of cyclophosphamide and capecitabine and highly fractionated metronomic administration to treat cancer, e.g., breast cancer which is a convenient and stable bi-layer oral tablet formulation of cyclophosphamide and capecitabine. Patent Number: W02015189807A1
Approved Chemist by Department of Foods and Drugs Administration (Goa FDA), Government of Goa, India, as an Expert in Chemical and Instrumentation, vide certificate No. 66(2637)/MFG/APP/DFDA/06/11227